Epigral approves ₹5.00 dividend, auditor ratification at 19th AGM
Epigral Limited shareholders approved a final dividend of ₹5.00 per share for FY26 at the 19th AGM held on June 08, 2026. All six resolutions, including the adoption of financial statements and the re-appointment of directors Mr. Ankit Patel and Mr. Karana Patel, were passed with a majority exceeding 99.98%. The meeting also ratified the appointment of M/s. S R B C & Co LLP as statutory auditors and M/s K V Melwani & Associates as cost auditors for FY 2026-27.
*this image is generated using AI for illustrative purposes only.
Epigral Limited shareholders approved a final dividend of ₹5.00 per share for the financial year ended March 31, 2026, at its 19th Annual General Meeting held on June 08, 2026. The meeting, conducted via video conferencing, saw the ratification of statutory and cost auditor appointments for FY 2026-27. All six ordinary resolutions were passed with the requisite majority, as per the scrutinizer's report submitted to the exchanges.
The voting results were disclosed to the National Stock Exchange of India Limited and BSE Limited on June 09, 2026. Mr. Kaushik Shah of M/s K J Shah & Co served as the scrutinizer for the e-voting process. Remote e-voting commenced on June 04, 2026, and concluded on June 07, 2026, with 43 shareholders attending the meeting through video conferencing.
Resolutions Approved
Shareholders approved the following resolutions during the meeting:
| Sr. No | Particulars |
|---|---|
| 1. | To receive, consider, approve and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the Financial Year ended March 31, 2026 together with reports of the Board of Directors & Auditors thereon. |
| 2. | To declare Final Dividend of Rs. 5.00 (50%) per equity share of Rs. 10/- each fully paid-up for the Financial Year ended March 31, 2026. |
| 3. | To appoint a Director in place of Mr. Ankit Patel (DIN: 02180007), who retires by rotation and being eligible, offers himself for re-appointment. |
| 4. | To appoint a Director in place of Mr. Karana Patel (DIN: 01727321), who retires by rotation and being eligible, offers himself for re-appointment. |
| 5. | To consider ratification of Appointment of M/s. S R B C & Co LLP, Chartered Accountants as the Statutory Auditors of the Company for F. Y. 2026-27. |
| 6. | To consider ratification of remuneration payable M/s K V Melwani & Associates, Cost Accountants as the Cost Auditors of the Company for the F.Y. 2026-27. |
Voting Summary
The resolutions received overwhelming support from shareholders. The total number of votes polled for the financial statements resolution was 29,364,229, with 99.9999% in favour. The dividend resolution saw 29,373,601 votes polled, with 99.9999% in favour. The re-appointment of directors Mr. Ankit Patel and Mr. Karana Patel received 99.9879% and 99.9879% votes in favour, respectively. The ratification of statutory auditors and cost auditors also passed with 99.9999% votes in favour.
Historical Stock Returns for Epigral
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.84% | +0.90% | -13.37% | -20.43% | -37.39% | +182.86% |
How will the ₹5.00 per share dividend impact Epigral's cash flow and capital allocation plans for FY 2026-27?
What strategic priorities are expected to drive Epigral's growth following the approval of the audited financial statements for FY 2026?
Are there any anticipated changes in the company's dividend policy or payout ratio in the coming years?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
